BCG Vaccine for Intradermal Injection Market was valued at USD 0.65 Billion in 2022 and is projected to reach USD 1.10 Billion by 2030, growing at a CAGR of 6.8% from 2024 to 2030.
As we transition from 2023 to 2033, the outlook for the BCG vaccine market is poised for further growth, but with several key factors influencing its trajectory. The demand for the BCG vaccine for intradermal injection is expected to increase, driven by the continued need for TB prevention, especially in developing countries. However, new challenges are emerging, such as the potential introduction of alternative TB vaccines and changes in immunization policies. Additionally, the rise in global awareness regarding vaccine safety, coupled with an increasing number of anti-vaccination sentiments in some regions, may impact overall demand. Technological advancements in vaccine delivery mechanisms, such as needle-free intradermal injections, are likely to shape the future landscape, making the vaccine more accessible and easier to administer.
The 2023 to 2033 forecast is also shaped by the World Health Organization’s (WHO) targets for TB eradication, which could lead to stronger government initiatives to increase BCG vaccination coverage. Furthermore, innovations in diagnostic tools and vaccine effectiveness assessments will likely play a role in determining the global demand for BCG vaccines. As countries strive toward eradicating TB, there is also the possibility of enhanced public-private partnerships to boost production and distribution capabilities, ensuring that the vaccine reaches remote and underserved populations.
Get an In-Depth Research Analysis of the Global BCG Vaccine for Intradermal Injection Market Size And Forecast [2025-2032]
The BCG Vaccine for Intradermal Injection Market has witnessed significant shifts between 2018 and 2022, largely influenced by global healthcare dynamics, technological advancements, and rising awareness of tuberculosis (TB) prevention. The market saw strong demand during this period due to increased awareness about TB control, particularly in high-risk regions. A surge in vaccination campaigns, especially in countries with high TB incidence rates, contributed to the demand for the BCG vaccine. The pandemic also played a crucial role in affecting vaccine supply chains, leading to occasional shortages, while also highlighting the importance of maintaining immunization schedules to prevent TB outbreaks.
Merck
Sanofi Pasteur
Japan BCG Lab
Shanghai Institute of Biological Products
Serum Institute of India
Intervax
GSBPL
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global BCG Vaccine for Intradermal Injection Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global BCG Vaccine for Intradermal Injection Market
Hospital
Clinic
Other
Based on Types the Market is categorized into Below types that held the largest BCG Vaccine for Intradermal Injection market share In 2023.
BCG for Immunization
BCG for Therapy
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ BCG Vaccine for Intradermal Injection Market Research Analysis
1. Introduction of the Global BCG Vaccine for Intradermal Injection Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global BCG Vaccine for Intradermal Injection Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global BCG Vaccine for Intradermal Injection Market, By Type
6. Global BCG Vaccine for Intradermal Injection Market, By Application
7. Global BCG Vaccine for Intradermal Injection Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global BCG Vaccine for Intradermal Injection Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/